GDD type | N (%) |
---|---|
Ahmed FP7 | 101/110 (91.8) |
Baerveldt 250 mm2 | 9/110 (8.2) |
Location for tube placement | |
Anterior chamber | 83/110 (75.5) |
Pars plana | 27/110 (24.5) |
Operative and post-GDD complications | |
Corneal decompensation | 20/110 (19.0) |
Retinal detachment | 7/110 (6.4) |
Encapsulated bleb | 27/110 (24.5) |
GDD dislocation | 5/110 (4.5) |
Tube erosion | 7/110 (6.4) |
Tube dislocation | 2/110 (1.8) |
Tube-endothelial touch | 3/110 (2.7) |
Tube blockage | 2/110 (1.8) |
Chronic hypotonya | 5/110 (4.5) |
Phthisis bulbi | 4/110 (3.6) |
No light perception | 4/110 (3.6) |
Patients with complications | 62/110 (56.4) |
Additional post-GDD procedures | |
Mean ± SD (range) | 1.5 ± 1.4 (0–6) |
Revision of existing GDD | 2/110 (1.8) |
Tube shortening/revision | 16/110 (14.5) |
Tube coverage | 5/110 (4.5) |
Drainage of choroidal effusion | 5/110 (4.5) |
Implantation of additional GDD | 12/110 (10.9) |
GDD explantation | 3/110 (2.7) |
Diode cyclophotocoagulation | 17/110 (15.4) |
Phaco/PCIOL | 9/110 (8.2) |
Pars plana vitrectomy | 10/110 (9.1) |
Scleral buckle procedure | 1/110 (0.9) |
Needling of filtering bleb/5-FU injections | 27/110 (24.5) |
Healon®-injection (anterior chamber) | 26/110 (23.6) |
DSAEK/PKP | 20/110 (19.0) |
Enucleation | 1/110 (0.9) |